Thieno[2,3-c]pyrrol-4-one derivatives as erk inhibitors
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
21.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!